Table:
pain
anxiety, nerves or depression
insomnia
other

%
95% confidence interval
%
95% confidence interval
%
95% confidence interval
%
95% confidence interval

from
to
from
to
from
to
from
to

total
52.5
43.6
61.2
18.8
13.0
26.5
18.3
11.7
27.6
10
6.7
15.5

age group

15 to 24
53.9
39.2
68.0
22.1
13.0
35.0
10.3
5.3
19.0
f
..
..

25 to 44
45.4
31.9
59.6
24.4
14.2
38.8
22.2
11.7
37.9
f
..
..

45 and older
60.9
45.3
74.5
f
..
..
f
..
..
12
6.1
21.1

male
49.3
38.4
60.2
19.8
12.4
29.9
20.8
12.0
33.5
10.2
5.8
17.3

age group

15 to 24
53.3
35.1
70.7
22.4
11.5
39.1
f
..
..
f
..
..

25 to 44
46.8
30.7
63.6
f
..
..
f
..
..
f
..
..

45 and older
51.0
32.0
69.7
f
..
..
f
..
..
f
..
..

female
60.3
46.5
72.7
f
..
..
12.5
6.7
22.1
10.6
5.7
18.9

age group

15 to 24
55.1
31.1
76.9
..
..
f
..
..
f
..
..

25 to 44
40.7
20.2
65.0
f
..
..
f
..
..
f
..
..

45 and older
78.7
60.3
90.0
f
..
..
f
..
..
f
..
..

Statement: 18.3% of the past-year sdmnm cannabis users identified alleviating insomnia as the primary purpose for their medical use.
Question: what was the percentage of the past-year sdmnm cannabis users who identified alleviating insomnia as the primary purpose for their medical use.
Answer: [18.3]